IMR Press / CEOG / Volume 49 / Issue 12 / DOI: 10.31083/j.ceog4912266
Open Access Review
Robotic versus Vaginal Surgery for Treatment of Pelvic Organ Prolapse: A Comprehensive Review
Show Less
1 Department of Obstetrics and Gynecology, San Paolo teaching hospital, ASST Santi Paolo e Carlo, 20142 Milan, Italy
2 Department of San Paolo bachelor school of Nursing, San Paolo teaching hospital, ASST Santi Paolo e Carlo, 20142 Milan, Italy
*Correspondence: Stefano.terzoni@asst-santipaolocarlo.it (Stefano Terzoni)
Academic Editor: Christos Iavazzo
Clin. Exp. Obstet. Gynecol. 2022, 49(12), 266; https://doi.org/10.31083/j.ceog4912266
Submitted: 20 July 2022 | Revised: 26 August 2022 | Accepted: 30 August 2022 | Published: 7 December 2022
Copyright: © 2022 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.
Abstract

Objectives: The aim of this study was to compare robotic-assisted surgery (RS) and vaginal surgery (VS) for pelvic organ prolapse (POP) through an updated review. Mechanism: We performed a comprehensive review from March 1, 2022 up to April 1, 2022. All comparative studies that compared RS and VS for the management of POP were included. Findings in Brief: A total of 10 non-randomized studies including 1424 participants were included in the review. The results revealed that robotic surgery (RS) was associated with longer operative time, less estimated blood loss, and fewer postoperative complications. There were no differences between the length of hospital stays, intraoperative complications and effectiveness between the two groups. Conclusions: RS and VS have comparable efficacy, although RS was associated with less blood loss and postoperative complications. The choice of surgical procedure depends on the surgeon’s discretion and the patient’s preference.

Keywords
pelvic organ prolapse (POP)
sacrocolpopexy (SC)
robotic surgery (RS)
robotic-assisted sacrocolpopexy (RASC)
vaginal surgery (VS)
1. Introduction

Pelvic organ prolapse (POP) consists of the fall of the anterior vaginal wall (also known as cystocele) or posterior vaginal wall (or rectocele), uterus, or the apex of the vagina if a hysterectomy has been previously performed [1]. POP is common in 40%–60% of parous women; the most common sites for repair are the anterior compartment, followed by the posterior compartment [2].

The risk of surgery for POP by age 80 is estimated to be around 12.2% [3, 4]. Therapies for symptomatic POP consist of surgical and conservative options. Non-surgical options for POP include pelvic floor physical therapy (including Kegel exercises) and pessary placement [5]. According to a Cochrane review, there is no rigorous evidence from randomized controlled trials on the use of conservative options in the management of POP [6].

Surgical interventions for pelvic organ prolapse include apical abdominal reconstructive repairs (mainly sacrocolpopexy) through open, laparoscopic, or robotic approaches; apical vaginal reconstructive repairs (sacrospinous hysteropexy, uterosacral hysteropexy, iliococcygeal hysteropexy, hysteropexy); and vaginal obliterative procedures [7].

Most patients with symptomatic POP can be managed properly with the vaginal approach, while correction of apical descent or multicompartmental prolapse is usually treated abdominally [8].

In sacrocolpopexy (SC), the surgeon fixes the vaginal vault and/or cervix by grafting into the sacrum. Sacrocolpopexy with laparotomic access achieves a 90% success rate. However, this procedure involves longer operation time, higher morbidity and higher hospital costs. These downsides can be avoided by performing SC with a less invasive, laparoscopic access (LASC) or its robotic equivalent (RASC) [9, 10].

The da Vinci Surgical System® (Intuitive Surgical Inc., Sunnyvale, CA, USA) is a surgical robot that increases magnification, enables 3-dimensional vision, eliminates physiological tremor, and has 7 degrees of freedom in order to simplify complex laparoscopic tasks such as suturing and knot tying, key techniques in SC [9].

Two randomized control trial (RCT) studies compared RASC with LASC without finding any difference in functional outcomes between the robotic and laparoscopic approaches at 1 year. In the RASC group, however, there were significantly longer operative times, greater pain reported by patients up to 5 weeks after surgery, and higher surgical costs [10, 11]. After these studies, three reviews state that it seems reasonable to conclude that SCs of any type RASC or LASC are equally effective [12, 13, 14]. Therefore, the choice of surgical method should be determined by evaluating complication rates, postoperative recovery, surgeon preference, and surgical factors such as uterine size or adnexal pathology [15].

Vaginal approach to the peritoneal cavity may decrease the rate of intraoperative complications by avoiding bowel manipulation and extreme Trendelenburg positioning, as well as by shortening the need for general anesthesia. However, this approach can implicate higher mesh exposure rates and poorer functional outcomes [12, 16, 17].

The aim of this study was to review the literature about vaginal and robotic surgical approaches in POP.

2. Materials and Methods

We conducted a comprehensive literature review, focusing on a particular research area or topic, in order to provide an opportunity to identify key concepts, research gaps, when the topic has not been extensively examined or is complex or heterogeneous in nature. The steps to perform this review were: identifying the research question, identifying relevant studies, making a selection of studies, tracking data, collecting, summarizing, and reporting results [18, 19, 20]. The sixth step (stakeholder consultation) was not performed in this review because it is optional [18, 19, 20, 21].

We follow the Preferred Reporting Items for Systematic reviews and Meta-Analyzes extension for Scoping Reviews (PRISMA-ScR) Checklist [22].

2.1 Identifying the Research Question

The PICO question (Patients/intervention/comparison/outcome) was the following: P = female patients with pelvic organ prolapse (any grade/type), I = robotic surgery, C = vaginal surgery, O = any outcome studied by the authors (e.g., intraoperative bleeding, surgical timing, postoperative pain) [23].

The population studied includes high-income countries with the availability of robotic surgery, without geographic differences.

2.2 Identifying Relevant Studies

PubMed, Scopus, ISI Web of Science, and Cochrane Library were searched for relevant literature from 01 March, 2022 up to 01 April, 2022. A combination of keywords such as “vaginal surgery”, “robotic surgery”, and “pelvic organ prolapse” was used (Supplementary Table 1).

2.3 Study Selection

Titles and abstracts of the records reported through the database review were independently screened by two reviewers. Only papers published after 1998 (any language) were considered. Additional manual search was performed to allow retrieval of other potentially relevant articles, using the reference lists of key papers. Full texts of records recommended by at least one reviewer were screened independently by the same two reviewers and assessed for inclusion in the review [24]. In case of disagreement between the reviewers, this was resolved with consensus.

2.4 Data Charting and Sorting

Arksey and O’Malley [18] recommend charting and sorting the data according to key themes and questions to organize the data. Our table includes authors, year of publication, research design, study sample, type of intervention, population age, patient characteristics, degree of prolapse, and hospital variables (Table 1, Ref. [17, 25, 26, 27, 28, 29, 30, 31, 32, 33]).

Table 1.Characteristics of the studies.
Study Year Design Sample Type of surgery Age Patient characteristics Prolapse Grade Hospital Variables
Anand [25] 2016 retrospective cohort study RS 100 VS: Mayo-McCall culdoplasty (MMC) 63.2 ± 10.9 y -BMI VS advanced (grade 3 or 4) anterior vaginal compartment prolapse than either RS (p = 0.004) None
VS 252 RS: robotically assisted laparoscopic sacrocolpopexy (RSC) VS 68.9 ± 10.4 RS 28
RS 59.9 ± 9.3 y (p < 0.001) VS 27.4 (p = 0.55)
-Vaginal Deliveries
RS 3.0 (1.7)
VS 2.6 (1.0) (p = 0.41)
-Prior prolapse surgeries
RS 61.4%
VS 35.6% (p < 0.001)
-ASA 3+
RS 8.9%
VS 25.2% (p < 0.001)
-Need to splint to defecate or a sensation of incomplete bowel evacuation
RS 5.9%
VS 14.9% (p = 0.03)
-Chronic pain of any kind
RS 11.9%
VS 3.4% (p = 0.006)
Anand [26] 2017 retrospective cohort study see previous article VS: Mayo-McCall culdoplasty (MMC) see previous article see previous article -Operative time
RS: robotically assisted laparoscopic sacrocolpopexy (RSC) RS 228 min (185, 285) (p < 0.001)
VS 101 min (82, 123)
-Estimated blood loss mL
RS 100 (88, 200)
VS 200 (150, 300) (p < 0.001)
-Any intraop complication
RS 23.8% (24/101)
VS 4.6% (5/109) (p < 0.001)
-Urinary tract infection
RS 7.4% (7/94)
VS 26.9% (28/104) (p < 0.001)
-Any grade wound complication
RS 20.2% (19 e/94)
VS 49.0% (51 f/104) (p < 0.001)
-Length of hospitalization,
RS d 1 (1, 2)
VS 2 (2, 3) (p < 0.001)
-Total cost of hospitalization (in 2013 dollars)
RS $12,859 ($11,997, $14,575)
VS $8879 ($7967, $10,124) (p < 0.001)
Anand [27] 2017 retrospective cohort study see previous article VS: Mayo-McCall culdoplasty see previous article see previous article -Intraoperative complications was highest in the RS (p < 0.01)
RS: robotically assisted laparoscopic sacrocolpopexy (RSC) -Postoperative complications (including urinary tract infection) was significantly greater in the VS group than the RS group (37.0% vs 23.4%; p = 0.04)
Jambusaria [17] 2015 retrospective cohort study VS 38 VS: transvaginal mesh repairs VS (60.4 ± 6.2) -BMI -Operative time min
RS 38 RS: robotic-assisted laparoscopic sacrocolpopexy (RALSC) RS (54.8 ± 10.4) RS 26.6 (5.9) RS 274.5 (45.9)
(p = 0.01) VS 27.5 (3.9) (p = 0.48) VS 178.1 (50.6) (p < 0.001)
-Vaginal Deliveries -Estimated blood loss mL
RS 3.0 (1.7) RS 106
VEC 2.6 (1.0) (p = 0.26) VS 131 (p = 0.3)
-Prior prolapse surgeries -Length of hospitalization day
RS 11/38 RS 1.4 (1)
VS 3/38 (p = 0.002) VS 1.2 (0.4) (0.12)
Jaresova [28] 2021 prospective study VS 20 VS: vaginal high uterosacral ligament suspension VS 69 (66−74) -BMI -Operative time min
RS 20 RS: robotic sacrocolpopexy RS 65 (59−68) RS 27 (24−31) RS 181 (165−201)
VS 25 (22−29) VS 162 (128−186) p = 0.008)
-Vaginal Deliveries -Estimated blood loss mL
RS 2 (2−3) RS 43 mL (28−63)
VS 3 (2−3) VS 75 mL (75−100)
-Prior prolapse surgeries
RS 5 (25)
VS 0
Nguyen [29] 2020 retrospective cohort study VS 87 VS: Transvaginal uterosacral ligament suspension VS 62 (8) -BMI RS: severe POP including POP-Q stage III or IV apical prolapse -VS: higher NVP score (4.2 ± 2.4 vs 2.6 ± 1.8, p < 0.0001), maximum NVP score (6.9 ± 2.7 vs 5.8 ± 1.9, p = 0.01) compared to RS
RS 103 RS: robotic sacrocolpopexy RS 58 (11) (p = 0.005) RS 28 (4) -Prolonged urethral catheterization
VS 30 (5) (p = 0.06) RS 0 versus VG 6, 6%; p = 0.03
-Vaginal Deliveries -Operative time min
RS 3 (2, 4) RS 175 (34)
VS 3 (2, 4) (p = 0.44) VS 157 (52) (p < 0.0001)
-Prior prolapse surgeries -Estimated blood loss mL
RS 7 (8%) RS 99 (70)
VS 10 (10%) (p = 0.69) VS 194 (131) (p < 0.0001)
Robinson [30] 2013 retrospective cohort study VS 66 VS: sacrospinous ligament suspension, uterosacral ligament suspension, colpocleisis, and vaginal mesh VS 74.5 (65–92) -BMI -Intraoperative complications was similar (RS, 11.5% vs VS, 4.5%; p = 0.194)
RS 70 placement RS 69.0 (65–81) (p < 0.0001) RS 26.6 (18.0–42.9) -VS: more postoperative complications (43.3% vs 20.9%; p = 0.005)
RS: sacrocolpopexy or sacrocervicopexy performed with a macroporous polypropylene mesh and permanent suture VS 26.0 (18.0–37.0) (p = 0.059) More urinary tract
-Vaginal Deliveries infections (18.2% vs 6.0%; p = 0.030)
RS 2 -Operative time min
VS 3 (p = 0.162) RS 201 ± 70 (87–417)
VS 139 ± 60 (36–243) (p < 0.0001)
-Estimated blood loss mL
RS 91 ± 97 (5–500)
VS 172 ± 140 (5–700) (p < 0.0001)
-Length of hospitalization day
RS 2.0 ± 0.5 (0–4)
VS 2.3 ± 0.5 (2–4) (0.013)
Vallabh-Patel [31] 2016 retrospective cohort study VS 42 VS: vaginal high uterosacral ligament suspension VS 65.2 (11.0) -BMI -No intraoperative complications
RS 26 RS: robotic high uterosacral ligament suspension after a total hysterectomy RS 54.12 (10.86) (p < 0.0001) RS 28.246 (4.465) -Operative time min
VS 27.3 (6.3) (p = 0.589) RS 153.35 (37.59)
-Vaginal Deliveries VS 143 (29) (p = 0.1894)
RS 2.462 (1.334) -Estimated blood loss mL
VS 2.5 (1.4) (p = 0.7632) RS 106 (121.4)
VS 133 (106.9) (p = 0.0762)
-Length of hospitalization day
RS 1
VS 1.07 (p = 1.000)
Westermann [32] 2017 prospective study VS 39 VS: vaginal VS 61.9 (12.2) -BMI -RS had lower recorded NVP scores in the first 24 hours (p = 0.04)
RS 39 hysterectomy with vaginal reconstructive surgery RS 56.3 (8.6) (p = 0.02) RS 25.8 (6.2) -Operative time min
RS: vaginal VS 27.8 (9.6) (p = 0.11) RS 230.0 (33.0)
hysterectomy with robotic sacrocolpopexy -Vaginal Deliveries VS 172.0 (33.0) (p < 0.0001)
RS 2 (1.0) -Estimated blood loss mL
VS3 (2.0) (p = 0.18) RS 100.0 (75.0)
-Prior prolapse surgeries VS 150.0 (100.0) (p = 0.01)
RS 2 (5.1) -Length of hospitalization day
VS 2 (5.1) (p > 0.999) RS 1
VS 1 (p = 0.4)
Yune [33] 2018 retrospective cohort study VS 333 VS: transvaginal high uterosacral ligament suspension VS 64.2 (12.6) -BMI Grades of anterior (VS 2.58 vs RS 2.81; p = 0.025) and posterior POP (VS 1.96 vs RS 2.26; p = 0.001) -Postoperative retention
RS 151 RS: robotic-assisted sacrocolpopexy RS 57.9 (11.4) (p < 0.001) RS28.0 (4.85) RS 15 (9.9%)
VS 27.7 (5.65) (p = 0.367) VS 113 (33.9%) <0.001
-Vaginal Deliveries -Length of hospitalization day
RS 2.70 (1.35) RS 1.4 (0.8)
VS 3.21 (1.75) (p = 0.006) VS 1.4 (0.8) (p = 0.654)
RS, Robotic surgery; VS, vaginal surgery; ASA, American Society of Anesthesiologists; NVP, nurse verbal pain.
2.5 Collating, Summarizing and Reporting the Results

To collect, summarize, and report the approaches of the articles a data charting module was used, with the same structure as Table 1.

3. Results

Electronic database search yielded a total of 577 results. After exclusion of duplicates, 243 citations remained. Of these, 233 were not relevant for review based on title and abstract screening. 10 studies were considered for full-text evaluation. No articles were added by searching the reference lists. Therefore, 10 studies met the inclusion criteria and were added to the review [17, 25, 26, 27, 28, 29, 30, 31, 32, 33]. All included studies were prospective and retrospective studies published from 2013 to 2021 and described a total of 1424 patients. A total of 547 women underwent robotic surgery and 877 underwent vaginal surgery. The main characteristics of these studies are listed in Table 1.

3.1 Baseline Characteristics of the Women

Overall, the literature considered women with many different baseline characteristics, thus preventing a quantitative synthesis of results. In particular, most papers reported statistically significant differences at baseline in the characteristics of patients undergoing robotic and vaginal surgery; in 9 papers [17, 25, 26, 27, 29, 30, 31, 32, 33] it was unclear whether the statistical analysis accounted for these differences, thus eliminating potential bias.

Regarding previous surgeries, in the study by Anand et al. [25] a higher percentage of patients in the robotic group had previous sling placement for stress urinary incontinence (24.8%) than patients in the vaginal group (8.6%) (p <0.001). The robotic-assisted surgery (RS) group had less need for splinting for defecation or a feeling of incomplete bowel evacuation (6.9%) than the vaginal surgery (VS) group (23.0%; p < 0.001) [25]. Patients in the robotic group had less anal incontinence at baseline (5.9%) than the VS group (14.9%; p = 0.03) [25]. In Jambusaria et al. [17] it was found that the RS group also had a significantly higher rate of previous hysterectomies (p = 0.02), previous POP surgery (p = 0.02) and concomitant hysterectomies (p = 0.01). Also in the case of Jaresova [28], no patient in the vaginal group had undergone previous surgery for POP or stress urinary incontinence, compared with 10% in the robotic group.

Regarding the grade of prolapse, a higher percentage of advanced (grade 3 or 4) anterior vaginal compartment prolapse was found in Anand et al. [25] VS than in both RS (p = 0.004). In Jambusaria et al. [17] the preoperative functional and quality-of-life scores of the PFDI-20 (Pelvic Floor Distress Inventory, validated and recommended by the International Consultation on Incontinence as grade A for the assessment of pelvic floor dysfunction) [34], the PFIQ (Pelvic Floor Impact Questionnaire, a supplementary health-related quality-of-life questionnaire specifically for women with pelvic floor disorders) [35] and the PISQ (Pelvic Organ Prolapse/Incontinence Sexual Questionnaire) [36] were similar in both groups, as was the objective measurement of the anterior edge of prolapse from the POP-Q (Pelvic Organ Prolapse Quantification System, which is based on specific measurements of defined points in the midline of the vaginal wall) [37] measurements. Nguyen describes that women in the robotic group had more severe POP, including a higher percentage of stage III or IV POP-Q apical prolapse than those in the VS group [29]. In Robinson et al. [30] the stage of apical prolapse was more advanced in the RS group than in the VS group. In Yune [33], VS patients also had lower grades of anterior POP (VS 2.58 vs RS 2.81; p = 0.025) and posterior POP (VS 1.96 vs RS 2.26; p = 0.001).

We noted a variety of vaginal surgical techniques. The main vaginal surgical technique used was uterosacral ligament suspension [28, 29, 30, 31, 33], followed by Mayo-McCall culdoplasty [25, 26, 27] and vaginal mesh placement [17]. Almost all robotic surgeries were sacrocolpopexy.

Women in the vaginal group were significantly older in all studies, while there were no differences in body mass index (BMI) and number of vaginal deliveries between the groups. Some studies analyzed previous surgery for POP in the patients’ medical history, finding them more frequent in the robotic surgery group in Anand et al. [25, 26, 27], Jambusaria et al. [17], Jaresova et al. [28] while in N’Guyen et al. [29] previous surgery for POP was more common in the vaginal group. In Westermann et al. [32], there were no differences between the groups.

3.2 Clinical Outcomes

Most studies analyzed operative duration, intraoperative bleeding, postoperative pain, and incidence of urinary tract infections (UTI) and LUTS (Lower Urinary Tract Symptoms).

The operative time was significantly longer in the RS in all studies, although the estimated blood loss was greater in the VS in each study (Table 1).

Overall, VS produced higher rates of urinary tract complications, regardless of the reason for surgery. Robinson et al. [30] and Anand et al. [25, 26, 27] reported a higher incidence of UTI among women undergoing Mayo-McCall culdoplasty compared to robotic laparoscopic sacrocolpopexy (18.2% vs 6.0%; p = 0.030, and 37.0% vs 23.4%; p = 0.04, respectively). Postoperative urinary retention rates were higher in the Yune et al. [33] cohorts of women operated vaginally for transvaginal suspension of the high uterosacral ligament (RS 15, 9.9%, VS 113, 33.9%, p < 0.001), and prolonged urethral catheterization (>12 hours) occurred more frequently in the Nguyen cohort of women undergoing transvaginal suspension of the uterosacral ligament (RS 0 versus VG 6, 6%; p = 0.03). Robotic surgery had lower NVP (nurse verbal pain) scores in the first 24 hours [29, 33]. We found no differences in terms of hospitalization days (Table 1).

The follow-up of Anand et al. [25, 26, 27] was analyzed using a written questionnaire. Quality of life between the two groups did not differ with regard to long-term symptoms post-treatment of POP in women who completed the questionnaire. In the comparison between VS and RS, survival without retreatment did not differ significantly in the first 5 years after surgery (hazard ratio (HR), 1.14; 95% confidence interval (CI), 0.24–5.38; p = 0.86) [26]. Significant improvement was also found in Jambusaria [17] in both groups’ anatomical POP-Q measures of posterior, anterior, and apical support defects (p = 0.001), as well as among functional measures of PFDI, PFIQ, or PISQ scores. In Vallabh [31], researchers contacted all patients by telephone and completed the PFDI-20 questionnaire. The mean follow-up times in the vaginal and robotic groups were 22 (standard deviation (sd) = 7) and 29 (sd = 10) months, respectively (p = 0.05). No difference was observed in postoperative PDFI-20 total scores between the RS and VS groups, 5.5 (9.2) and 3.0 (7.3) (p = 0.33). There was significant improvement between preoperative and postoperative PFDI-20 scores, as expected (preoperative RS 96.4 (59.3%) vs postoperative RS 5.5 (9.17); p < 0.001. Preoperative VS 94.6 (66.3%) vs postoperative VS 2.98 (7.29%); p < 0.001) [31]. Regarding the Westermann [32] follow-up, no significant differences in percentage change were found for either PCS or MCS (Physical and mental health composite scores are generated using 12 questions. The scores range from 0, indicating the lowest level of health, to 100, indicating the highest level of health) by surgical group [32]. Significant improvement was found between preoperative and postoperative scores for each surgical technique using the SF-12 (Short Form 12-item Survey) which provides information on mental and physical health status (Windsor, 2006) (preoperative RS 51.70 (18%) vs postoperative RS 2 weeks 33.84 (8.79%); p < 0.001. Preoperative VS 42.82 (17.00) vs postoperative VS 33.06 (12.21); p = 0.006).

In Jaresova [28], follow-up was not described because the purpose of the study was to verify and compare the angles and time spent in the Trendelenburg position in three procedures commonly performed to correct POP: vaginal approach, laparoscopic SC, and robotic SC. It was found that the maximum median Trendelenburg angle was significantly greater for the laparoscopic approach than for the vaginal and robotic approaches, with the vaginal approach requiring the least tilt. In Nguyen [29] and Robinson [30], the purpose of the studies was to analyze perioperative adverse event rates (NVP score, postoperative pain scores, surgical and hospitalization times, and perioperative adverse event rates), described above, so we do not have follow-up. There is also no follow-up in Yune [33], because the purpose of the study was to compare urinary retention rates between the transvaginal and transabdominal robotic approaches.

4. Discussion

There is a variety of methods performed by surgeons for POP repair, each technique has its own success and complication rates, and surgeons should arrange individualized plans for each patient, considering risks and benefits. McCall Culdoplasty is the surgical correction of enterocele during vaginal hysterectomy [38]. In a larger retrospective study (n = 693), the McCall Culdoplasty technique demonstrated 82% patient satisfaction and a reintervention rate of 5.2% [39]. No recent RCTs evaluating McCall culdoplasty have been performed. A 2011 prospective study evaluating this technique at the time of vaginal hysterectomy found that the only risk factor for failure at 2 years, defined as Pelvic Organ Prolapse Quantification (POPQ) stage 3, was a history of fetal macrosomia (44.4 vs 6.9%, p = 0.000) [40]. The satisfaction rate of uterosacral ligament suspension was estimated to be around 89%, with only 5.5% requiring reoperation [41]. A meta-analysis of 32 studies reported 81.2%, 98.3%, and 87.4% success for the anterior, apical, and posterior compartments, but with a high ureteral injury rate of 1–11% [42]. Minimally invasive surgery for abdominal sacrocolpopexy is designed to promote rapid postoperative recovery, reducing 30-day complication rates, blood transfusion, long hospital stay, and hospital readmission compared with abdominal sacrocolpopexy [43, 44]. In 2014, a retrospective study compared abdominal sacrocolpopexy (ASC) (n = 58) with a minimally invasive abdominal surgical approach, including robotic-assisted sacrocolpopexy (RS) n = 262 and laparoscopic-assisted sacrocolpopexy (LS) n = 273. No differences in anatomical failures were observed, but complications such as postoperative ileus or small bowel obstruction were greater in the ASC group (20 vs 12.7%, p = 0.001). Women undergoing the robotic procedure had similar surgical success rates compared to the vaginal route or laparoscopic approach. Once the feasibility of undergoing minimally invasive surgery is established, robotic surgery could be considered an alternative to classic laparoscopic surgery, with equal efficacy [45, 46, 47, 48]. Robotic sacrocolpopexy has longer operative times, while vaginal procedures have been associated with higher estimated blood loss [45, 49].

The literature has considered many heterogeneous procedures, often enrolling women with significant differences in baseline characteristics [50]. In Vanspauwen et al. [51], it is clear that vaginal vault prolapse repair post hysterectomy is preferred in older patients. Jha and Moran [52] report that 11% of physicians surveyed in the United Kingdom would change the procedure of choice for posthysterectomy vaginal vault prolapse if the patient was not sexually active [25]. When asked what factors influence the choice of type of surgery for primary or recurrent correction of a pelvic organ prolapse, Montoya et al. [50] found that for primary correction the vaginal route was preferred, while in case of prolapse recurrence the abdominal route was preferred. In the study, factors considered by surgeons for primary or recurrent POP were age, desire to maintain vaginal function, comorbid conditions, and stage of POP. In choosing the type of laparoscopic technique (laparoscopic SC or robotic SC), the relevant decision factors were the degree of prolapse and the surgeon’s experience [50]. POP is a public health problem and affects the lives of millions of adult women. Surgery can offer effective treatment. The problem of pelvic prolapse will become larger and larger, requiring more and more surgeries each year [53, 54, 55]. It is estimated that the demand for pelvic prolapse treatment will increase by 35% from 2010 to 2030, and surgical intervention rates for pelvic organ prolapse will increase by 42.7% by 2050 [4, 56, 57]. Therefore, it will be increasingly necessary to provide subspecialty medical care.

5. Conclusions

To date, this appears to be the first paper to examine the state of the art of robotic and vaginal surgery for pelvic organ prolapse. Surprisingly, very few papers met the inclusion criteria, although we tried to include any study design, type of surgery, and clinical outcome. Despite these limitations, the general conclusion can be drawn that RS and VS have comparable efficacy in terms of prolapse correction. The choice of robotic or vaginal approach is based on the patient’s characteristics and preferences. This review suggests that robotic apical suspension may be associated with less pain and narcotic use than vaginal suspension and that robotic surgery has lower rates of postoperative urinary complications, such as urinary tract infections, urinary retention, and prolonged urethral catheterization. For repeated surgical prolapse procedures, the most commonly reported route is the robotic approach. When possible, choosing the robotic approach appears to provide more favorable functional outcomes and lower infection rates.

Author Contributions

NA conceived the topic; NA, GG and ST retrieved the literature; NA, ST and MA wrote the paper; AMM provided relevant methodological support and supervision. All authors read and approved the final manuscript.

Ethics Approval and Consent to Participate

Not applicable.

Acknowledgment

Not applicable.

Funding

This research received no external funding.

Conflict of Interest

The authors declare no conflict of interest. Giorgia Gaia is serving as one of the Guest editors of this journal. Anna Maria Marconi is serving as one of the Editorial Board members and Guest editors of this journal.We declare that Giorgia Gaia and Anna Maria Marconi had no involvement in the peer review of this article and has no access to information regarding its peer review. Full responsibility for the editorial process for this article was delegated to Christos Iavazzo.

References
[1]
Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, et al. The standardisation of terminology of lower urinary tract function: Report from the standardisation sub-committee of the International Continence Society. Neurourology and Urodynamics. 2002; 21: 167–178.
[2]
Handa VL, Garrett E, Hendrix S, Gold E, Robbins J. Progression and remission of pelvic organ prolapse: a longitudinal study of menopausal women. American Journal of Obstetrics and Gynecology. 2004; 190: 27–32.
[3]
Wu JM, Matthews CA, Conover MM, Pate V, Jonsson Funk M. Lifetime Risk of Stress Urinary Incontinence or Pelvic Organ Prolapse Surgery. Obstetrics and Gynecology. 2014; 123: 1201–1206.
[4]
Wu JM, Hundley AF, Fulton RG, Myers ER. Forecasting the Prevalence of Pelvic Floor Disorders in U.S. Women: 2010 to 2050. Obstetrics and Gynecology. 2009; 114: 1278–1283.
[5]
Alas AN, Anger JT. Management of Apical Pelvic Organ Prolapse. Current Urology Reports. 2015; 16: 33.
[6]
Hagen S, Stark D, Maher C, Adams E. Conservative management of pelvic organ prolapse in women. The Cochrane Database of Systematic Reviews. 2006; CD003882.
[7]
Ko KJ, Lee K. Current surgical management of pelvic organ prolapse: Strategies for the improvement of surgical outcomes. Investigative and Clinical Urology. 2019; 60: 413–424.
[8]
Geoffrion R, Larouche M. Guideline no. 413: Surgical Management of Apical Pelvic Organ Prolapse in Women. Journal of Obstetrics and Gynaecology Canada. 2021; 43: 511–523.e1.
[9]
Kim YT, Kim SW, Jung YW. Robotic Surgery in Gynecologic Field. Yonsei Medical Journal. 2008; 49: 886–890.
[10]
Paraiso MFR, Jelovsek JE, Frick A, Chen CCG, Barber MD. Laparoscopic Compared with Robotic Sacrocolpopexy for Vaginal Prolapse: a randomized controlled trial. Obstetrics and Gynecology. 2011; 118: 1005–1013.
[11]
Anger JT, Mueller ER, Tarnay C, Smith B, Stroupe K, Rosenman A, et al. Robotic Compared with Laparoscopic Sacrocolpopexy: a randomized controlled trial. Obstetrics and Gynecology. 2014; 123: 5–12.
[12]
Callewaert G, Bosteels J, Housmans S, Verguts J, Van Cleynenbreugel B, Van der Aa F, et al. Laparoscopic versus robotic-assisted sacrocolpopexy for pelvic organ prolapse: a systematic review. Gynecological Surgery. 2016; 13: 115–123.
[13]
De Gouveia De Sa M, Claydon LS, Whitlow B, Dolcet Artahona MA. Robotic versus laparoscopic sacrocolpopexy for treatment of prolapse of the apical segment of the vagina: a systematic review and meta-analysis. International Urogynecology Journal. 2016; 27: 355–366.
[14]
Pan K, Zhang Y, Wang Y, Wang Y, Xu H. A systematic review and meta-analysis of conventional laparoscopic sacrocolpopexy versus robot-assisted laparoscopic sacrocolpopexy. International Journal of Gynecology and Obstetrics. 2016; 132: 284–291.
[15]
Schachar JS, Matthews CA. Robotic-assisted repair of pelvic organ prolapse: a scoping review of the literature. Translational Andrology and Urology. 2020; 9: 959–970.
[16]
Maher C, Feiner B, Baessler K, Schmid C. Surgical management of pelvic organ prolapse in women. The Cochrane Database of Systematic Reviews. 2013; CD004014.
[17]
Jambusaria LH, Murphy M, Lucente VR. One-Year Functional and Anatomic Outcomes of Robotic Sacrocolpopexy Versus Vaginal Extraperitoneal Colpopexy with Mesh. Female Pelvic Medicine and Reconstructive Surgery. 2015; 21: 87–92.
[18]
Arksey H, O’Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology. 2005; 8: 19–32.
[19]
Levac D, Colquhoun H, O’Brien KK. Scoping studies: advancing the methodology. Implementation Science. 2010; 5: 69.
[20]
Peters MDJ, Godfrey CM, Khalil H, McInerney P, Parker D, Soares CB. Guidance for conducting systematic scoping reviews. International Journal of Evidence-Based Healthcare. 2015; 13: 141–146.
[21]
Peters MDJ, Marnie C, Tricco AC, Pollock D, Munn Z, Alexander L, et al. Updated methodological guidance for the conduct of scoping reviews. JBI Evidence Synthesis. 2020; 18: 2119–2126.
[22]
Tricco AC, Lillie E, Zarin W, O’Brien KK, Colquhoun H, Levac D, et al. PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation. Annals of Internal Medicine. 2018; 169: 467–473.
[23]
Brown D. A Review of the PubMed PICO Tool: Using Evidence-Based Practice in Health Education. Health Promotion Practice. 2020; 21: 496–498.
[24]
Frigerio M, Inzoli A, Barba M. Pelvic organ prolapse and vaginal cancer: A systematic literature review. International Journal of Gynaecology and Obstetrics. 2022. (in press)
[25]
Anand M, Weaver AL, Fruth KM, Gebhart JB. Factors Influencing Selection of Vaginal, Open Abdominal, or Robotic Surgery to Treat Apical Vaginal Vault Prolapse. Female Pelvic Medicine and Reconstructive Surgery. 2016; 22: 236–242.
[26]
Anand M, Weaver AL, Fruth KM, Trabuco EC, Gebhart JB. Symptom Relief and Retreatment after Vaginal, Open, or Robotic Surgery for Apical Vaginal Prolapse. Female Pelvic Medicine and Reconstructive Surgery. 2017; 23: 297–309.
[27]
Anand M, Weaver AL, Fruth KM, Borah BJ, Klingele CJ, Gebhart JB. Perioperative Complications and Cost of Vaginal, Open Abdominal, and Robotic Surgery for Apical Vaginal Vault Prolapse. Female Pelvic Medicine and Reconstructive Surgery. 2017; 23: 27–35.
[28]
Jaresova A, Warda H, Macharia A, Hacker MR, Li J. Comparison of Trendelenburg Angles in Vaginal, Laparoscopic, and Robotic Uterovaginal Apical Prolapse Repairs. Journal of Minimally Invasive Gynecology. 2021; 28: 1868–1875.
[29]
Nguyen JN, Yang ST. Perioperative outcomes after robotic versus vaginal surgery for pelvic organ prolapse. Journal of Robotic Surgery. 2020; 14: 415–421.
[30]
Robinson BL, Parnell BA, Sandbulte JT, Geller EJ, Connolly A, Matthews CA. Robotic Versus Vaginal Urogynecologic Surgery: a retrospective cohort study of perioperative complications in elderly women. Female Pelvic Medicine and Reconstructive Surgery. 2013; 19: 230–237.
[31]
Vallabh-Patel V, Saiz C, Salamon C. Subjective and Objective Outcomes of Robotic and Vaginal High Uterosacral Ligament Suspension. Female Pelvic Medicine and Reconstructive Surgery. 2016; 22: 420–424.
[32]
Westermann LB, Crisp CC, Mazloomdoost D, Kleeman SD, Pauls RN. Comparative Perioperative Pain and Recovery in Women Undergoing Vaginal Reconstruction Versus Robotic Sacrocolpopexy. Female Pelvic Medicine and Reconstructive Surgery. 2017; 23: 95–100.
[33]
Yune JJ, Cheng JW, Wagner H, Kim J, Hardesty JS, Siddighi S. Postoperative urinary retention after pelvic organ prolapse repair: Vaginal versus robotic transabdominal approach. Neurourology and Urodynamics. 2018; 37: 1794–1800.
[34]
de Arruda GT, dos Santos Henrique T, Virtuoso JF. Pelvic floor distress inventory (PFDI)—systematic review of measurement properties. International Urogynecology Journal. 2021; 32: 2657–2669.
[35]
Barber MD, Chen Z, Lukacz E, Markland A, Wai C, Brubaker L, et al. Further validation of the short form versions of the pelvic floor Distress Inventory (PFDI) and pelvic floor impact questionnaire (PFIQ). Neurourology and Urodynamics. 2011; 30: 541–546.
[36]
Rogers RG, Rockwood TH, Constantine ML, Thakar R, Kammerer-Doak DN, Pauls RN, et al. A new measure of sexual function in women with pelvic floor disorders (PFD): the Pelvic Organ Prolapse/Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR). International Urogynecology Journal. 2013; 24: 1091–1103.
[37]
Persu C, Chapple CR, Cauni V, Gutue S, Geavlete P. Pelvic Organ Prolapse Quantification System (POP-Q) - a new era in pelvic prolapse staging. Journal of Medicine and Life. 2011; 4: 75–81.
[38]
McCall ML. Posterior culdeplasty; surgical correction of enterocele during vaginal hysterectomy; a preliminary report. Obstetrics and Gynecology. 1957; 10: 595–602.
[39]
Webb MJ, Aronson MP, Ferguson LK, Lee RA. Posthysterectomy vaginal vault prolapse: primary repair in 693 patients. Obstetrics and Gynecology. 1998; 92: 281–285.
[40]
Cam C, Karateke A, Asoglu MR, Selcuk S, Namazov A, Aran T, et al. Possible cause of failure after McCall culdoplasty. Archives of Gynecology and Obstetrics. 2011; 283: 791–794.
[41]
Karram M, Goldwasser S, Kleeman S, Steele A, Vassallo B, Walsh P. High uterosacral vaginal vault suspension with fascial reconstruction for vaginal repair of enterocele and vaginal vault prolapse. American Journal of Obstetrics and Gynecology. 2001; 185: 1339–1343.
[42]
Margulies RU, Lewicky-Gaupp C, Fenner DE, McGuire EJ, Clemens JQ, DeLancey JOL. Complications requiring reoperation following vaginal mesh kit procedures for prolapse. American Journal of Obstetrics and Gynecology. 2008; 199: 678.e1–678.e4.
[43]
Nosti PA, Andy UU, Kane S, White DE, Harvie HS, Lowenstein L, et al. Outcomes of Abdominal and Minimally Invasive Sacrocolpopexy: a retrospective cohort study. Female Pelvic Medicine and Reconstructive Surgery. 2014; 20: 33–37.
[44]
Linder BJ, Occhino JA, Habermann EB, Glasgow AE, Bews KA, Gershman B. A National Contemporary Analysis of Perioperative Outcomes of Open versus Minimally Invasive Sacrocolpopexy. Journal of Urology. 2018; 200: 862–867.
[45]
Mueller MG, Jacobs KM, Mueller ER, Abernethy MG, Kenton KS. Outcomes in 450 Women after Minimally Invasive Abdominal Sacrocolpopexy for Pelvic Organ Prolapse. Female Pelvic Medicine and Reconstructive Surgery. 2016; 22: 267–271.
[46]
Cucinella G, Calagna G, Romano G, Di Buono G, Gugliotta G, Saitta S, et al. Robotic versus laparoscopic sacrocolpopexy for apical prolapse: a case-control study. Il Giornale Di Chirurgia. 2016; 37: 113–117.
[47]
Parkes IL, Shveiky D. Sacrocolpopexy for Treatment of Vaginal Apical Prolapse: Evidence-Based Surgery. Journal of Minimally Invasive Gynecology. 2014; 21: 546–557.
[48]
Li C, Hua K. The current status of sacrocolpopexy in the management of apical prolapse. Minerva Ginecologica. 2020; 72: 165–170.
[49]
Chang C, Chen C, Chang S. Comparing the outcomes and effectiveness of robotic-assisted sacrocolpopexy and laparoscopic sacrocolpopexy in the treatment of pelvic organ prolapse. International Urogynecology Journal. 2022; 33: 297–308.
[50]
Montoya TI, Grande KB, Rahn DD. Apical Vaginal Prolapse Surgery: practice patterns and factors guiding route of repair. Female Pelvic Medicine and Reconstructive Surgery. 2012; 18: 315–320.
[51]
Vanspauwen R, Seman E, Dwyer P. Survey of current management of prolapse in Australia and New Zealand. The Australian & New Zealand Journal of Obstetrics & Gynaecology. 2010; 50: 262–267.
[52]
Jha S, Moran P. The UK national prolapse survey: 5 years on. International Urogynecology Journal. 2011; 22: 517–528.
[53]
Dieter AA, Wilkins MF, Wu JM. Epidemiological trends and future care needs for pelvic floor disorders. Current Opinion in Obstetrics and Gynecology. 2015; 27: 380–384.
[54]
Wilkins MF, Wu JM. Lifetime risk of surgery for stress urinary incontinence or pelvic organ prolapse. Minerva Ginecologica. 2017; 69: 171–177.
[55]
Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. International Urogynecology Journal. 2013; 24: 1783–1790.
[56]
Wu JM, Kawasaki A, Hundley AF, Dieter AA, Myers ER, Sung VW. Predicting the number of women who will undergo incontinence and prolapse surgery, 2010 to 2050. American Journal of Obstetrics and Gynecology. 2011; 205: 230.e1–230.e5.
[57]
Kirby AC, Luber KM, Menefee SA. An update on the current and future demand for care of pelvic floor disorders in the United States. American Journal of Obstetrics and Gynecology. 2013; 209: 584.e1–584.e5.
Share
Back to top